v2.4.0.8
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
 3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Revenues        
Gross revenues $ 1,968,962 $ 1,753,812 $ 3,520,976 $ 1,753,812
Discounts 499,861 227,543 782,521 227,543
Revenues, net of discounts 1,469,101 1,526,269 2,738,455 1,526,269
Cost of Goods Sold        
Cost of goods sold 1,143,141 794,396 1,900,211 794,396
Gross Profit 325,960 731,873 838,244 731,873
Operating expenses:        
Selling expenses 253,513 341,778 350,516 341,778
Research and development 5,747 3,473 11,189 23,012
Royalty expense 176,597 161,404 396,334 322,809
Professional fees 245,443 571,326 667,705 608,723
General and administrative expenses 1,015,521 731,830 1,697,022 1,392,179
Depreciation and amortization expense 126,598 74,176 234,969 74,176
Product development fee - related party 230,000 210,000 500,000 412,700
Total Operating Expense 2,053,419 2,093,987 3,857,735 3,175,377
Loss from operations (1,727,459) (1,362,114) (3,019,491) (2,443,504)
Other (income) / expenses:        
Interest expense, net of interest income 413,016 296,135 782,482 296,135
Derivative liability (gain) / loss (375,334) 406,803 (1,245,925) 346,627
Net loss $ (1,765,141) $ (2,065,052) $ (2,556,048) $ (3,086,266)
Net loss per share attributable to common shareholders - basic and diluted $ (0.01) $ (0.02) $ (0.02) $ (0.04)
Weighted average number of common shares used in computing - basic and diluted 154,491,758 87,773,384 154,397,805 87,188,180